Sun-Protection Studies Heating Up, But Are Clouded By Secrecy

Clouded By Secrecy ("Cosmeceuticals") BRIGHT IDEA: Faith Strickland investigates aloe's immunoprotective effects. Another summer season is under way, and millions of people are sunning themselves by beaches and pools. These days, however, the public is more aware of the unhealthy effects of sun exposure and is using more skin-care products that contain sun-protective ingredients. As the competition heats up, cosmetic companies are increasingly on the lookout for new research on better ways t

Written byCarol Potera
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Clouded By Secrecy ("Cosmeceuticals")


BRIGHT IDEA: Faith Strickland investigates aloe's immunoprotective effects.
Another summer season is under way, and millions of people are sunning themselves by beaches and pools. These days, however, the public is more aware of the unhealthy effects of sun exposure and is using more skin-care products that contain sun-protective ingredients. As the competition heats up, cosmetic companies are increasingly on the lookout for new research on better ways to block the sun, and are courting academic and entrepreneurial scientists working in this area. But details on their work are scanty; secrecy shrouds most of their research efforts as cosmetic companies try to protect their market share.

"The job market is growing for scientists who want to work in dermatology," says Jonathan Klein, chief financial officer at Applied Genetics Inc., a privately held biotechnology company in Freeport, N.Y. "Your major cosmetic companies have major departments focused on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies